Literature DB >> 15161629

Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model.

Mimoun Nejjari1, Virginie Berthet, Véronique Rigot, Sullivan Laforest, Marie-France Jacquier, Nabil G Seidah, Lionel Remy, Erik Bruyneel, Jean-Yves Scoazec, Jacques Marvaldi, José Luis.   

Abstract

Although proprotein convertases are involved in tumor development, nothing is known about their role in metastatic dissemination. To investigate the involvement of convertase inhibition, we used human colon carcinoma cells overexpressing alpha1-antitrypsin Portland (alpha1-PDX, PDX39P cells), a potent convertase inhibitor. We previously reported that these cells bear uncleaved integrin alpha subunits and display an altered attachment to vitronectin that is correlated with defects in the intracellular signaling pathways activated by alphavbeta5 integrin ligation. In this study, we demonstrate that the inhibition of proprotein convertase activity either by overexpression of alpha1-PDX or with the synthetic inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone (dec-RVKR-cmk) led to a significant increase in cell migration supported by the alphavbeta5 integrin. A collagen gel invasion assay showed that PDX39P cells also displayed an invasive ability, contrary to control cells. Moreover, when injected to immunosuppressed newborn rats, PDX39P cells were highly invasive, as they induce 10 times more metastases than mock-transfected cells. In addition, the aggressiveness of PDX39P cells can be greatly reduced by a function-blocking monoclonal antibody (mAb) against the alphav subunit. It thus seems that inhibition of proprotein convertases enhances the in vivo invasiveness of colon tumor cells likely due to an increase in cell migration mediated by alphav integrins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161629      PMCID: PMC1615749          DOI: 10.1016/S0002-9440(10)63753-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

Review 1.  Cell adhesion: old and new questions.

Authors:  R O Hynes
Journal:  Trends Cell Biol       Date:  1999-12       Impact factor: 20.808

Review 2.  New aspects of integrin signaling in cancer.

Authors:  L V Parise; J Lee; R L Juliano
Journal:  Semin Cancer Biol       Date:  2000-12       Impact factor: 15.707

Review 3.  Multiple roles of integrins in cell motility.

Authors:  S P Holly; M K Larson; L V Parise
Journal:  Exp Cell Res       Date:  2000-11-25       Impact factor: 3.905

4.  Role of endoproteolytic processing in the adhesive and signaling functions of alphavbeta5 integrin.

Authors:  V Berthet; V Rigot; S Champion; J Secchi; F Fouchier; J Marvaldi; J Luis
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

5.  A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta -secretase.

Authors:  B D Bennett; P Denis; M Haniu; D B Teplow; S Kahn; J C Louis; M Citron; R Vassar
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

6.  Anti-beta4 integrin antibodies enhance migratory and invasive abilities of human colon adenocarcinoma cells and their MMP-2 expression.

Authors:  N Daemi; N Thomasset; J C Lissitzky; J Dumortier; M F Jacquier; C Pourreyron; P Rousselle; J A Chayvialle; L Remy
Journal:  Int J Cancer       Date:  2000-03-15       Impact factor: 7.396

Review 7.  Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins.

Authors:  A E Aplin; A Howe; S K Alahari; R L Juliano
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

8.  Elevated expression of proprotein convertases alters breast cancer cell growth in response to estrogen and tamoxifen.

Authors:  M Cheng; N Xu; B Iwasiow; N Seidah; M Chrétien; R P Shiu
Journal:  J Mol Endocrinol       Date:  2001-04       Impact factor: 5.098

9.  Site-specific epithelial-mesenchymal interactions in digestive neuroendocrine tumors. An experimental in vivo and in vitro study.

Authors:  J Dumortier; C Ratineau; J Y Scoazec; C Pourreyron; W Anderson; M F Jacquier; M Blanc; C Bernard; C Bellaton; L Remy; J A Chayvialle; C Roche
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

10.  Evidence showing that the two-chain form of vitronectin is produced in the liver by a selective furin cleavage.

Authors:  D Seger; S Shaltiel
Journal:  FEBS Lett       Date:  2000-09-01       Impact factor: 4.124

View more
  7 in total

1.  Surface expression of precursor N-cadherin promotes tumor cell invasion.

Authors:  Deborah Maret; Eugenia Gruzglin; Mohamad Seyed Sadr; Vincent Siu; Weisong Shan; Alexander W Koch; Nabil G Seidah; Rolando F Del Maestro; David R Colman
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

2.  Opposite roles of furin and PC5A in N-cadherin processing.

Authors:  Deborah Maret; Mohamad Seyed Sadr; Emad Seyed Sadr; David R Colman; Rolando F Del Maestro; Nabil G Seidah
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

3.  Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells.

Authors:  Nathalie Scamuffa; Geraldine Siegfried; Yannick Bontemps; Liming Ma; Ajoy Basak; Ghislaine Cherel; Fabien Calvo; Nabil G Seidah; Abdel-Majid Khatib
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

4.  Subtilisin-like proprotein convertase expression, localization, and activity in the human retina and optic nerve head.

Authors:  John A Fuller; Anne-Marie Brun-Zinkernagel; Abbot F Clark; Robert J Wordinger
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-01       Impact factor: 4.799

5.  The proprotein convertase PC5/6 is protective against intestinal tumorigenesis: in vivo mouse model.

Authors:  Xiaowei Sun; Rachid Essalmani; Nabil G Seidah; Annik Prat
Journal:  Mol Cancer       Date:  2009-09-08       Impact factor: 27.401

6.  Chromogranin A and its fragments as regulators of small intestinal neuroendocrine neoplasm proliferation.

Authors:  Francesco Giovinazzo; Simon Schimmack; Bernhard Svejda; Daniele Alaimo; Roswitha Pfragner; Irvin Modlin; Mark Kidd
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

7.  Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls.

Authors:  Sergio Pérez-Holanda; Ignacio Blanco; Manuel Menéndez; Luis Rodrigo
Journal:  BMC Cancer       Date:  2014-05-21       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.